Related Experiment Video
Updated: Sep 16, 2025
04:03
Author Spotlight: Evaluating the Therapeutic Efficacy of Moving Cupping Along Meridians for Acute Exacerbation of COPD
Published on: September 27, 2024
901
Lung Function Decline in COPD - Relations to Changes in Symptom Burden, Inflammation, and Comorbidities
Juan Wang1,2, Björn Ställberg3, Maria Hårdstedt1,4,5,6
1Department of Medical Sciences, Clinical Physiology, Uppsala University, Uppsala, Sweden.
COPD
|July 7, 2025
Summary
Increased symptom burden and inflammation worsen lung function decline in COPD patients over seven years. Lower symptom burden and higher lung function at baseline were linked to slower decline.
Area of Science:
- Pulmonary Medicine
- Respiratory Research
- Clinical Epidemiology
Background:
- Chronic Obstructive Pulmonary Disease (COPD) is a progressive lung disease.
- Understanding factors influencing COPD progression is crucial for patient management.
- Comorbidities, symptom burden, and inflammation are potential contributors to lung function decline.
Purpose of the Study:
- To investigate the associations between comorbidities, symptom burden, inflammatory biomarkers, and lung function decline in COPD patients.
- To identify predictors of lung function deterioration over a 7-year period.
Main Methods:
- Longitudinal study of 572 COPD subjects from the "Tools for Identifying Exacerbations in COPD" study.
- Lung function (FEV1) decline assessed over 7 years.
- Symptom burden measured using mMRC, CAT, and CCQ; inflammatory markers (CRP) analyzed.
Main Results:
- Lower baseline symptom burden and higher lung function were associated with slower absolute FEV1 decline.
- Increased symptom burden (mMRC, CAT, CCQ) and elevated C-reactive protein (CRP) levels were positively associated with both absolute and relative FEV1 decline.
- Atrial fibrillation was linked to a larger relative FEV1 decline.
Conclusions:
- Changes in systemic inflammation and symptom burden over time are significant predictors of 7-year lung function decline in COPD.
- These findings highlight the importance of monitoring symptom progression and inflammatory markers for managing COPD.
Related Concept Videos
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.9K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.9K
01:20Chronic Obstructive Pulmonary Disease-II: Pathophysiology
3.1K
Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Chronic Inflammation
3.1K
01:20COPD: Pathogenesis and Clinical Features
533
Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
533
01:26COPD: Management Using Bronchodilators and Corticosteroids
322
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
322
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.9K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.9K
01:22Chronic Obstructive Pulmonary Disease
1.4K
COPD is defined as a heterogeneous lung condition marked by persistent respiratory symptoms such as dyspnea, cough, and sputum production, caused by abnormalities in the airways that cause airflow obstruction.
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
Smoking is a primary risk factor for COPD, with over 80% of patients having a history of it. Patients typically experience progressive dyspnea or labored breathing, frequent coughing, and recurrent pulmonary infections. Many eventually succumb to respiratory failure, characterized by...
1.4K